Potential anti- Pythium insidiosum therapeutics identified through screening of agricultural fungicides
Microbiology Spectrum · 2024
DOI: 10.1128/spectrum.01620-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2024. Verfasst von Hanna Yolanda und 9 weiteren Autor:innen. Beteiligte Einrichtung: Program in Translational Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. Hauptthemen laut MEDLINE: Pythium, Fungicides, Industrial, Pythiosis, Imidazoles. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Council of Thailand (NRCT), Mahidol University (MU).
Abstract (Originalsprache)
Pythiosis is a life-threatening infectious disease caused by the oomycete Pythium insidiosum . Clinical manifestations of pythiosis include an eye, blood vessel, skin, or gastrointestinal tract infection. Pythiosis has been increasingly reported worldwide, with an overall mortality rate of 28%. Radical surgery is required to save patients’ lives due to the limited efficacy of antimicrobial drugs. Effective medical treatments are urgently needed for pythiosis. This study aims to find anti- P . insidiosum agents by screening 17 agricultural fungicides that inhibit plant-pathogenic oomycetes and validating their efficacy and safety. Cyazofamid outperformed other fungicides as it can potently inhibit genetically diverse P. insidiosum isolates while exhibiting minimal cellular toxicities. The calculated therapeutic scores determined that the concentration of cyazofamid causing significant cellular toxicities was eight times greater than the concentration of the drug effectively inhibiting P. insidiosum . Furthermore, other studies showed that cyazofamid exhibits low-to-moderate toxicities in animals. The mechanism of cyazofamid action is likely the inhibition of cytochrome b , an essential component in ATP synthesis. Molecular docking and dynamic analyses depicted a stable binding of cyazofamid to the Qi site of the P. insidiosum ’s cytochrome b orthologous protein. In conclusion, our search for an effective anti- P . insidiosum drug indicated that cyazofamid is a promising candidate for treating pythiosis. With its high efficacy and low toxicity, cyazofamid is a potential chemical for treating pythiosis, reducing the need for radical surgeries, and improving recovery rates. Our findings could pave the way for the development of new and effective treatments for pythiosis. IMPORTANCE Pythiosis is a severe infection caused by Pythium insidiosum . The disease is prevalent in tropical/subtropical regions. This infectious condition is challenging to treat with antifungal drugs and often requires surgical removal of the infected tissue. Pythiosis can be fatal if not treated promptly. There is a need for a new treatment that effectively inhibits P. insidiosum . This study screened 17 agricultural fungicides that target plant-pathogenic oomycetes and found that cyazofamid was the most potent in inhibiting P. insidiosum . Cyazofamid showed low toxicity to mammalian cells and high affinity to the P. insidiosum’s cytochrome b , which is involved in energy production. Cyazofamid could be a promising candidate for the treatment of pythiosis, as it could reduce the need for surgery and improve the survival rate of patients. This study provides valuable insights into the biology and drug susceptibility of P. insidiosum and opens new avenues for developing effective therapies for pythiosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Program in Translational Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
- Department of Parasitology, School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia.
- Excellent Center for Drug Discovery, Faculty of Science, Mahidol University, Bangkok, Thailand.
- Department of Biotechnology, Faculty of Science, Mahidol University, Bangkok, Thailand.
- Research Center, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
- Bioinformatics and Systems Biology Program, School of Bioresources and Technology and School of Information Technology, King Mongkut's University of Technology Thonburi, Bangkhuntien, Bangkok, Thailand.
ORCID-Profile: Theerapong Krajaejun
Förderung
- National Research Council of Thailand (NRCT)
- Mahidol University (MU)
Zitieren
APA
Yolanda, H., Jearawuttanakul, K., Wannalo, W., Kanjanasirirat, P., Borwornpinyo, S., Rujirawat, T., Payattikul, P., Kittichotirat, W., Wichadakul, D., & Krajaejun, T. (2024). Potential anti- Pythium insidiosum therapeutics identified through screening of agricultural fungicides. Microbiology Spectrum. https://doi.org/10.1128/spectrum.01620-23
Vancouver
Yolanda H, Jearawuttanakul K, Wannalo W, Kanjanasirirat P, Borwornpinyo S, Rujirawat T, et al. Potential anti- Pythium insidiosum therapeutics identified through screening of agricultural fungicides. Microbiology Spectrum. 2024. doi:10.1128/spectrum.01620-23
BibTeX
@article{Yolanda2024,
author = {Yolanda, Hanna and Jearawuttanakul, Kedchin and Wannalo, Warawuth and Kanjanasirirat, Phongthon and Borwornpinyo, Suparerk and Rujirawat, Thidarat and Payattikul, Penpan and Kittichotirat, Weerayuth and Wichadakul, Duangdao and Krajaejun, Theerapong},
title = {Potential anti- Pythium insidiosum therapeutics identified through screening of agricultural fungicides},
journal = {Microbiology Spectrum},
year = {2024},
doi = {10.1128/spectrum.01620-23}
}
EUVIMED